Medical specialists from Belgium tagged as investigators in clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell
Total 14 results
-
Ann JanssensSeen in:
- Leuven, Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
Trials:- NCT05254743 (Principal Investigator)
-
Eric Van Den Neste, MD, PhDSeen in:
- Brussels, Cliniques Universitaires Saint Luc
Trials:- NCT01295593 (Principal Investigator)
Conditions: -
Evelyne Willems, MDSeen in:
- Liege, CHU Sart Tilman
- Liège, CHU Liege
- Liège, CHU de Liege
Trials:- NCT03083574 (Sub-Investigator)
- NCT00603330 (Sub-Investigator)
- NCT03852407 (Sub-Investigator)
Conditions:- Refractory Chronic Graft Versus Host Disease (cGVHD);
- Graft-versus-host Disease;
- Poor Graft Function;
- Low Donor T-cell Chimerism;
- Myelodysplastic Syndromes;
- Multiple Myeloma;
- Hodgkin Lymphoma;
- Non Hodgkin Lymphoma;
- Myeloproliferative Disorder;
- Chronic Lymphoid Leukemia;
- Acute Myeloid Leukemia in Remission;
- Myeloproliferative Syndrome;
- Chronic Myeloid Leukemia in Remission;
- Acute Lymphoid Leukemia in Remission
-
Fritz OffnerSeen in:
- Gent, Universitair Ziekenhuis Gent
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
-
Gaetan VanstraelenSeen in:
- Liege, Verviers, CHR Verviers-Onco
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Greet BriesSeen in:
- Herentals, AZ St-Elisabeth
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Helen VellemansSeen in:
- Yvoir, CHU UCL Namur
- Yvoir, CHU UCL Namur site Godinne
Trials:- NCT04965493 (Principal Investigator)
Conditions: -
Hélène Schoemans, MD PhDSeen in:
- Leuven, UZ Leuven
Trials:- NCT03852407 (Sub-Investigator)
-
Lien DeleuSeen in:
- West Flanders, Roeselare, AZ Delta
Trials:- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Rik Schots, MD PhDSeen in:
- Brussels, UZ Brussel
Trials:- NCT03852407 (Sub-Investigator)
-
Sophie Servais, MDSeen in:
- Liège, CHU de Liege
Trials:- NCT03852407 (Sub-Investigator)
-
Thierry ConnerotteSeen in:
- Other, Ottignies, Clinique Saint Pierre
- Ottignies, Clinique Saint Pierre Ottignies
- Ottignies-Louvain-la-Neuve, BR Clinic Saint Pierre Ottignies
Trials:- NCT04666038 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT04053933 (Principal Investigator)
-
Vanessa DelrieuSeen in:
- Haine-Saint-Paul, Groupe Jolimont
- Haine-Saint-Paul, Hopital de Jolimont
Trials:- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
Conditions: -
Vanessa Van HendeSeen in:
- East Flanders, Sint-Niklaas, Vzw - Vitaz
- Oost-Vlaanderen, Sint-Niklaas, Vitaz
Trials:- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT06097364 (Principal Investigator)
Clinical Trials on Leukemia, Lymphocytic, Chronic, B-Cell
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...United States
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer Research Center/University...WithdrawnB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia
-
French Innovative Leukemia OrganisationTerminatedB-cell Chronic Lymphocytic Leukemia (B-CLL)France
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
Shanghai Zhangjiang Biotechnology Limited CompanySuspendedB-cell Chronic Lymphocytic LeukemiaChina
-
Mundipharma Research LimitedTerminatedB-cell Chronic Lymphocytic LeukemiaSpain
-
National Cancer Institute (NCI)TerminatedB-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
CelgeneCompletedB-cell Chronic Lymphocytic LeukemiaUnited States, Spain, United Kingdom, Canada, Belgium, Czechia, Hungary, Italy, Poland, Israel, Germany, Ireland, France, New Zealand, Denmark, Australia, Netherlands, Romania, Russian Federation, Sweden, Austria, South Africa, Colo... and more
-
French Innovative Leukemia OrganisationRoche Pharma AGCompletedB-cell Chronic Lymphocytic Leukemia CLLFrance